tiprankstipranks
Trending News
More News >
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI

Karyopharm Therapeutics (KPTI) Revenue

Compare
1,205 Followers

Karyopharm Therapeutics Revenue

Karyopharm Therapeutics had a revenue of 44.04M in the quarter ending Sep 30, 2025, with 16.12%. This bring the company's revenue in the last twelve months to 142.53M, Decreased 3.83%. In the fiscal year ending Dec 31, 2024, Karyopharm Therapeutics had annual revenue of 145.24M with -0.55% growth.
Revenue (ttm)
142.53M
Revenue Growth
-3.98%
P/S Ratio
0.81
Revenue/Employee
$520,563
Employees
279
Market Cap
$118.33M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
145.24M-796.00K+99.45%
Dec 31, 2023
146.03M-11.04M+92.97%
Dec 31, 2022
157.07M-52.74M+74.86%
Dec 31, 2021
209.82M101.73M+194.12%
Dec 31, 2020
108.08M67.19M+264.31%
Dec 31, 2019
40.89M10.56M+134.80%
Dec 31, 2018
30.34M28.73M+1,890.09%
Dec 31, 2017
1.60M1.45M+1,042.21%
Dec 31, 2016
154.00K